CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses.
Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
Roquin 和 Regnase-1 蛋白结合并转录后调控促炎靶信使 RNA,以维持免疫稳态。Roquin-1 的 sanroque 突变或 Regnase-1 缺失均会导致系统性红斑狼疮样表型。通过分析 T 细胞缺乏 Roquin-1、其旁系同源物 Roquin-2 和 Regnase-1 蛋白表达的小鼠,我们通过比较单独和联合失活检测到重叠或独特的表型。这些表型包括 T 细胞的自发激活、代谢重编程和持续存在,从而导致自身免疫。
在此,我们定义了 Roquin-1 中用于结合 Regnase-1 的相互作用表面,其中包括 sanroque 残基。损害这种相互作用和靶标协同调控的 Roquin-1 突变诱导了滤泡辅助性 T 细胞、生发中心 B 细胞和自身抗体形成。这些突变还通过促进肿瘤特异性 T 细胞在肿瘤中的积累和降低耗竭标志物的表达,改善了其功能。
我们的数据揭示了 Roquin-1 与 Regnase-1 的物理相互作用是控制免疫细胞治疗中自身反应性和效应功能的枢纽。
Roquin and Regnase-1 proteins bind and post-transcriptionally regulate proinflammatory target messenger RNAs to maintain immune homeostasis. Either the sanroque mutation in Roquin-1 or loss of Regnase-1 cause systemic lupus erythematosus-like phenotypes.
Analyzing mice with T cells that lack expression of Roquin-1, its paralog Roquin-2 and Regnase-1 proteins, we detect overlapping or unique phenotypes by comparing individual and combined inactivation. These comprised spontaneous activation, metabolic reprogramming and persistence of T cells leading to autoimmunity.
Here, we define an interaction surface in Roquin-1 for binding to Regnase-1 that included the sanroque residue. Mutations in Roquin-1 impairing this interaction and cooperative regulation of targets induced T follicular helper cells, germinal center B cells and autoantibody formation. These mutations also improved the functionality of tumor-specific T cells by promoting their accumulation in the tumor and reducing expression of exhaustion markers.
Our data reveal the physical interaction of Roquin-1 with Regnase-1 as a hub to control self-reactivity and effector functions in immune cell therapies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。